Are Weight Loss Shots Covered by Insurance? A Global Policy Review for Semaglutide & GLP-1 Drugs
The emergence of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, particularly semaglutide (marketed as Wegovy for weight loss and Ozempic for diabetes), has revolutionized the medical treatment of obesity. These once-weekly injectables offer unprecedented weight loss results, positioning them as the most effective pharmacological tool since bariatric surgery. However, the cost of these revolutionary drugs, often exceeding […]